Biocon Limited (BOM:532523)
India · Delayed Price · Currency is INR 370.10
-9.60 (-2.53%)
At close: Mar 27, 2026
Biocon Market Cap
Biocon has a market cap or net worth of 598.96 billion as of March 27, 2026. Its market cap has increased by 50.29% in one year.
Market Cap
598.96B
Enterprise Value
765.80B
Revenue
168.27B
Ranking
n/a
PE Ratio
99.13
Stock Price
370.10
Market Cap Chart
Since April 7, 2004, Biocon's market cap has increased from 45.41B to 598.96B, an increase of 1,218.92%. That is a compound annual growth rate of 12.45%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Mar 27, 2026 | 598.96B | 13.95% |
| Dec 31, 2025 | 525.64B | 20.22% |
| Dec 31, 2024 | 437.25B | 46.69% |
| Dec 29, 2023 | 298.08B | -4.59% |
| Dec 30, 2022 | 312.41B | -27.97% |
| Dec 31, 2021 | 433.73B | -21.37% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Aarti Drugs | 30.17B |
| Titan Biotech | 18.02B |
| Hester Biosciences | 11.22B |
| Zenotech Laboratories | 2.16B |
| Genesis IBRC India | 1.31B |
| Bharat Immunologicals & Biologicals Corporation | 703.83M |
| Transgene Biotek | 172.76M |
| Hindustan Bio Sciences | 75.96M |